COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2

The Tn Antigen-Structural Simplicity and Biological Complexity

(2011) Tongzhong Ju et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Mucin Glycosylating Enzyme GALNT2 Regulates the Malignant Character of Hepatocellular Carcinoma by Modifying the EGF Receptor

(2011) Y.-M. Wu et al.   CANCER RESEARCH

Cancer vaccines and carbohydrate epitopes

(2011) Jamie Heimburg-Molinaro et al.   VACCINE

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Cosmc is an essential chaperone for correct protein O-glycosylation

(2010) Y. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent insights into the biological roles of mucin-type O-glycosylation

(2008) E Tian et al.   GLYCOCONJUGATE JOURNAL

Regulation of protein O-glycosylation by the endoplasmic reticulum–localized molecular chaperone Cosmc

(2008) Tongzhong Ju et al.   JOURNAL OF CELL BIOLOGY

Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice

(2008) Jianxin Fu et al.   JOURNAL OF CLINICAL INVESTIGATION

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma

(2008) Masatoshi Jinnin et al.   NATURE MEDICINE

Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature

(2008) Christine Kilcline et al.   PEDIATRIC DERMATOLOGY

Mucin-type O-glycosylation and its potential use in drug and vaccine development

(2007) Mads Agervig Tarp et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS